Please ensure Javascript is enabled for purposes of website accessibility

Why Lantheus Holdings Inc. Got Smacked Down Today

By Brian Orelli, PhD - Mar 14, 2017 at 1:13PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

A large shareholder is liquidating some of its shares.

What happened

Lantheus Holdings (LNTH 0.60%) is down 12% at 12:38 p.m. EDT after announcing that an existing shareholder plans to sell 3 million shares.

So what

Unlike a secondary offering where a company sells new shares, Lantheus Holdings won't get any cash for the sale. On the other hand, current investors also won't be diluted like they are during a secondary offering. It's no different than shares trading hands on the Nasdaq exchange, just in a much larger volume.

Balance sheet printed on a paper with a pen and magnifying glass on it.

Image source: Getty Images.

It appears that shares are down simply because it's a large shareholder, Avista Capital Partners, that's selling a large chunk of its shares. Lantheus Holdings has about 37 million shares outstanding, so this transaction represents about 8% of the outstanding shares. Investors are likely worried that there's some unknown issue that's leading Avista Capital to sell some of its shares.

But, alternatively, it could just be that the private equity firm needs to liquidate its assets for reasons that have nothing to do with Lantheus' future prospects. Before Lantheus Holdings came to market in 2015, it was backed by Avista Capital, which bought the segment from Bristol-Myers Squibb (BMY -0.53%) in 2008. With Lantheus trading at more than double its IPO price, Avista Capital may have decided that now is a good time to return some of the invested capital to its investors.

Now what

After selling the 3 million shares, Avista Capital will still own 33.2% of Lantheus, so it's not like the private equity firm is getting out completely.

Investors might be getting a good deal investing at this knocked-down price, although cautious investors might want to wait and see where the buyers of those 3 million shares will value Lantheus' shares.

Brian Orelli and The Motley Fool have no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Lantheus Holdings, Inc. Stock Quote
Lantheus Holdings, Inc.
LNTH
$83.34 (0.60%) $0.50
Bristol Myers Squibb Company Stock Quote
Bristol Myers Squibb Company
BMY
$74.46 (-0.53%) $0.40

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
390%
 
S&P 500 Returns
125%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 08/11/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.